Squadron Capital Management’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
Other funds holding VTYX
Squadron Capital Management's VTYX Position: Q1 2026 in Review
Squadron Capital Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 410,000 shares — an estimated $3.7M sold.
Squadron Capital Management first reported a position in VTYX in Q4 2025 and held it in 1 quarter. The position peaked at $3.7M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.
- Squadron Capital Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
- Squadron Capital Management sold 410,000 Ventyx Biosciences shares in Q1 2026, an estimated $3.7M.
- Squadron Capital Management first reported a position in Ventyx Biosciences in Q4 2025 and held it in 1 quarter.
- Squadron Capital Management's Ventyx Biosciences position peaked at $3.7M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.
Based on Squadron Capital Management's 13F filing for Q1 2026, filed 15 May 2026.